Ask with Ease. Retrieve with Rigor. Study Data Secured by RAG-Enabled Chat in Xbiom
The biopharmaceutical industry is entering a new era where the ability to harness data directly determines the speed and success of drug development. Clinical trials, nonclinical studies, and biomarker assays now generate massive volumes of complex data. When unified and...
How Leaders Can Shape Drug Success Through Data
The Case for Faster, Smoother Approvals Every day saved in the approval process matters. Faster reviews mean therapies reach patients sooner, investors see value earlier, and science delivers its impact without avoidable setbacks. The encouraging news is that most delays...
The Hidden Bottleneck Undermining Pharma’s Mission
Every pharma executive faces the same core challenge: developing safe, efficacious therapies that reach patients while delivering sustainable returns. The industry exists for one fundamental purpose: to discover, develop, and deliver innovative treatments that are both clinically proven and commercially...
The AI Revolution CMOs & CSOs Need Now
Modern pharmaceutical companies take a different path on their journey into the digital age. CMOs and CSOs must have a say. If you’re a Chief Medical Officer, Chief Scientific Officer or Clinical Development leader, you know the frustration all too...
Enterprise LLMs for BioPharma Therapeutics Development
Abstract Large Language Models (LLMs) have the potential to significantly accelerate therapeutics development while reducing costs and increasing innovation in the biopharmaceutical industry. However, two critical barriers prevent widespread adoption of this technology. First, competitive sensitivities and data sovereignty requirements...
PointCross at PHUSE SDE 2025 – South San Francisco
Date: Friday, 22 August 2025Location: Genentech, 350 DNA Way, South San Francisco, CA 94080 Event Theme: Revolutionising Healthcare: The Transformative Power of Data Analytics and AI The PHUSE SDE 2025 brought together experts from healthcare, technology, and regulatory sectors to...
Breaking Free from Clinical Data Chaos: The AI Revolution CMOs & CSOs Need Now
How modern pharmaceutical companies can finally catch up with the digital age If you’re a Chief Medical Officer, Chief Scientific Officer or Clinical Development leader, you know the frustration all too well. Your teams are drowning in data from multiple...
Bridge Over Troubled Data: How RAG Connects AI Dreams to BioPharma Reality
In the troubled waters of modern drug development, where clinical insights are scattered across countless studies and siloed systems, researchers are searching for something that can safely carry them from fragmented data to unified intelligence, simply. They need a bridge....
Achieving 100% Data Quality in SEND Submissions with SEND Assure
Ensuring the quality of data submitted to regulatory agencies like the FDA (CBER and CDER) is vital in the Life Sciences industry. For nonclinical studies, the standard format is SEND (Standard for the Exchange of Nonclinical Data). SEND provides a...
PointCross Life Sciences is a Ruby Sponsor of CDISC India Day 2025
PointCross Life Sciences was proud to participate in CDISC India Day 2025, hosted by Eli Lilly in Bengaluru. The one-day event brought together global CDISC leadership, regulatory experts, and life sciences professionals to discuss the latest trends and innovations in...
